Global and China Industrial Enzyme Industry Report, 2012-2014
  • Nov./2012
  • Hard Copy
  • USD $1,900
  • Pages:68
  • Single User License
    (PDF Unprintable)       
  • USD $1,800
  • Code: ZYM037
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,800
  • Hard Copy + Single User License
  • USD $2,100
Industrial enzyme which refers to the enzyme preparation used for industrial purposes can be applied to detergent, animal feed, bread, brewing (beer, wine, etc.), papermaking, textile, bio-ethanol and so forth; especially, food & brewing, feed and detergent are the most commonly application fields, and they consume about 75% of industrial enzyme together.

The industrial enzyme market size has been expanding in recent years with the improvement of R&D technology and the extension of application range. From 2001-2011, the global industrial enzyme market scale presented a CAGR of 6.8%, and in 2011 the global market valued USD3.5 billion, with a year-on-year growth rate of 6.1%. Through numerous mergers and acquisitions, the global industrial enzyme market concentration degree has been gradually raised. In 2011, Novozymes and DuPont (DuPont acquired Genencor) enjoyed market share of 47% and 21% respectively.

Through several decades of development, China has become an important production base of industrial enzyme, and its market size accounts for about 10% of the global size. Judging from Chinese economic situation and domestic demand, the industrial enzyme market of China is expected to embrace a faster growth rate of 10% or so than the global 6%-8% in the next three years, and it will reach at least RMB3 billion in 2014. Yet, foreign tycoons with patent monopoly and strong R&D capabilities have entered China in succession, while Chinese counterparts are lagged in R&D, therefore Chinese native enzyme preparation enterprises have weak competitiveness, and the Chinese market is still currently dominated by Novozymes, DuPont (Genencor) and other foreign brands.

However, in market segments like feedstuff, Chinese play, VTR, for example, occupy a significant position, with 16.5% share (by sales volume) in Chinese feed enzyme market in 2011. Meanwhile, local enterprises are not only increasing new products, but also striving to expand their production scale and enhance marketing; for instance, VTR invested the funds raised from IPO in “12,000 t/a Enzyme Preparation Project Phase II” in Inner Mongolia (early 2012); Hunan Hongyingxiang and Jinshi Development Zone signed an agreement for “300,000 standard tons/a Enzyme Preparation Project” (May, 2012). Therefore, based on local advantages, it is expected that Chinese companies will sweep more market shares.

The report covers the followings:

20120114.gif Status quo, regional distribution, competition pattern and prospect of global industrial enzyme industry;
20120114.gif Relevant policies, current situation, competitive landscape, import & export and prospect of Chinese industrial enzyme industry;
20120114.gif Impact of industrial enzyme downstream sectors like baked food, brewing, feedstuff and bio-ethanol in China;
20120114.gif Operation, enzyme preparation business and development prospect of 9 enzyme preparation suppliers at home and abroad (such as Novozymes, DuPont (Genencor), VTR, Youteer, etc.).

1 Overview of Industrial Enzyme 

2 Development of Global Industrial Enzyme Industry 
2.1 Status Quo
2.2 Regional Distribution
2.3 Competition Pattern
2.4 Development Prospect 

3 Development of China Industrial Enzyme Industry
3.1 Related Policies
3.2 Market 
3.3 Competitive Landscape
3.4 Import and Export
3.4.1 Import
3.4.2 Export
3.5 Development Outlook

4 Impact of Downstream on Chinese Enzyme Industry
4.1 Food Industry
4.1.1 Bakery
4.1.2 Condiments
4.2 Brewing Industry
4.2.1 Beer
4.2.2 Wine
4.2.3 Others
4.3 Detergent Industry
4.3 Feedstuff Industry
4.4 Papermaking and Textile Industry
4.4.1 Papermaking Industry
4.4.2 Textile Industry
4.5 Bio-ethanol Industry

5 Major Foreign Companies
5.1 Novozymes 
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure 
5.1.4 R&D Investment 
5.1.5 Enzyme Business
5.1.6 Development in China
5.2 Danisco (Genencor)
5.2.1 Profile
5.2.2 Operation
5.2.3 Development in China
5.3 DSM
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure 
5.3.3 Development in China
5.4 AB Enzymes
5.4.1 Profile
5.4.2 Operation
5.4.3 Development in China

6 Major Chinese Suppliers
6.1 Guangdong VTR
6.1.1 Profile
6.1.2 Operation
6.1.3 Revenue Structure
6.1.4 Customers and Suppliers
6.1.5 Capacity, Output and Sales Volume
6.1.6 Costs and Prices
6.1.7 Prospect 
6.2 Hunan Youteer 
6.2.1 Profile
6.2.2 Operation and Development Forecast 
6.3 Shandong Longda
6.3.1 Profile
6.3.2 Operation and Development Forecast 
6.4 KDN Biotech
6.4.1 Profile
6.4.2 Operation and Development Forecast 
6.5 Sunson
6.5.1 Profile
6.5.2 Operation and Development Forecast 

Global Industrial Enzyme Market Size and YoY Growth Rate, 2008-2011
Global Industrial Enzyme Market Structure (by Application)
Regional Distribution of Global Enzyme Preparation, 2011
Market Share of Global Industrial Enzyme Enterprises, 2011
Global Industrial Enzyme Market Size, 2011-2014E
Major Enzyme Enterprises and Their Competitive Edges in China
Enzyme Import Volume and Value in China, 2009-2012 
Average Enzyme Import Price in China, 2009-2012 
Enzyme Import Volume (by type) in China, Jan.-Aug. 2012
Enzyme Import Volume and Value (by Country and Region) in China, Jan.-Aug. 2012
Enzyme Export Volume and Value in China, 2009-2012
Average Enzyme  Export Price in China, 2009-2012
Enzyme Export Volume and Value (by Country and Region) in China, Jan.-Aug. 2012
Some New Industrial Enzyme Projects in China, by Aug. 2012
Pastry Output and YoY Growth Rate in China, 2007-2011
Revenue and Total Profit of Chinese Bakery Industry, 2008-2012 
Revenue and Total Profit of China’s Condiment and Fermentation Products Industry, 2008-2012
Soy Sauce Output and YoY Growth Rate in China, 2007-2012
Application of Enzyme Products in Beer Brewing
Beer Output and YoY Growth Rate in China, 2007-2012
Beer Sales Volume and Sales-output Ratio in China, 2007-2012
Revenue and Total Profit of China Beer Industry, 2008-2012
Wine Output and YoY Growth Rate in China, 2007-2012
Revenue and Total Profit of China Wine Industry, 2007-2012
Detergent Output in China, 2007-2012
Feedstuff Output (by Type) in China, 2011
Feedstuff Output (by Category) in China, 2011
Output of Pulp, Machine-made Paper and Paperboard in China, 2007-2012
Revenue of Pulp, Machine-made Paper and Paperboard in China, 2007-2012
Output of Cloth, Yarn and Silk Fabrics in China, 2008-2012
Revenue of China Textile Industry, 2007-2012
Revenue and EBIT of Novozymes, 2007-2011 
Investment Funds and ROIC of Novozymes, 2007-2011
Revenue of Novozymes (by Applicantion),  2011
Revenue of Novozymes (by Region) , 2011
R&D Investment and Its Proportion in Revenue of Novozymes, 2007-2011
Industrial Enzyme Revenue of Novozymes (by Product) , 2007-2011
Danisco’s Companies in China 
DSM’s Revenue and Operating Profit, 2010-2011
DSM’s Revenue (by Business), 2010-2011 
DSM’s Revenue (by Application), 2010-2011
DSM’s Revenue (by Origin), 2010-2011
DSM’s Revenue (by Sales Region), 2010-2011
Revenue and Profit of ABF Additive Business, 2009-2011
VTR’s Revenue and Profit , 2009-2011
VTR’s Enzyme Preparation Revenue (by Product or Dosage Form), 2009-2011
VTR’s Revenue (by Sales Model) , 2009-2011 
Namelist and Revenue Contribution of VTR’s Top 5 Clients, 2009-2011
Name list and Procurement of VTR’s Top 5 Suppliers, 2009-2011
VTR’s Enzyme Preparation Output (by Base), 2009-2011
VTR’s Enzyme Preparation Capacity, Output and Sales Volume (by Dosage Form), 2009-2011
VTR’s Enzyme Preparation Output and Sales Volume (by Product), 2009-2011
Procurement Quantity and Price of VTR’s Raw Materials, 2009-2011
Quantity and Proportion of VTR’s Self-produced and Purchased Enzyme Sources, 2009-2011
VTR’s Raw Material Procurement Capital and Proportion, 2009-2011
VTR’s Enzyme Preparation Price (by Product or Dosage Form), 2009-2011
VTR’s Product R&D Progress, by end 2011
VTR’s R&D Cost and % in Revenue, 2009-2011
VTR’s IPO Projects and Funds, 2012
VTR’s Revenue and Net Income, 2011-2014E
Revenue and Net Income of Hunan Youteer, 2008-2011
Revenue and Net Income of Hunan Youteer, 2011-2014E
Events of KDN Biotech, 2011-2012
Sunson's R&D Centers and Production Bases
Operating Revenue and Operating Income of Sunson, 2008-2009

China Animal Vaccine Industry Report, 2019-2025

Chinese animal vaccine industry showed a CAGR of 8% between 2013 and 2017, but it was depressed by the outbreak of African Swine Fever in 2018 with the market size edging down 2.5% on an annualized ba...

China Blood Product Industry Report, 2020-2026

With the dynamic adjustment in the catalog of medicines covered by national medical insurance system, the scope of clinical use of almost all blood products grows tremendously, so does the reimburseme...

China Vacuum Blood Collection Device Industry Report, 2019-2025

As laboratory medicine advances, favorable polices are issued and people live a better life and care more about their health, vacuum blood collection systems get increasingly used. In 2018, global vac...

China Human Vaccine Industry Report, 2019-2025

China has been the world’s biggest producer and consumer of human vaccines over four decades of planned vaccination, a program that has reduced incidence of multiple vaccine-targeted infectious diseas...

China Independent Clinical Laboratory Industry Report, 2019-2025

China's independent clinical laboratory industry is still in its infancy. In 2018, it only saw the penetration rate of about 5%, far below 40% or more in Europe, the United States and Japan. The main ...

Global and China Monoclonal Antibody Industry Report, 2019-2025

Global monoclonal antibody market can be presented as follows: 1. Monoclonal antibody drug market booms and is highly concentrated with the approvals for such drugs.Monoclonal antibody drugs have bee...

China Contract Research Organization (CRO) Industry Report, 2019-2025

The steadily growing global pharmaceutical industry where more and more new drugs have been approved, and the soaring spending on drug research and development in recent years, are a boon for global c...

China Blood Product Industry Report, 2019-2025

With the adjustment of the national medical insurance catalogue, the clinical application and reimbursement rate of almost all blood products have been greatly improved, and the market for blood produ...

China Human Vaccine Industry Report, 2018-2022

As the world’s largest producer of human vaccines, China has established a full-life-cycleregulatory system covering vaccine R&D, production, distribution, and vaccination. The lot release volum...

China Contract Research Organization(CRO) Industry Report, 2017-2021

Under the pressure from higher R&D costs, longer R&D cycle and lower R&D success rate in pharmaceutical industry worldwide, over 50 percent of pharmaceutical enterprises have had the devel...

China Vacuum Blood Collection Device Industry Report, 2017-2021

China’s vacuum blood collection device industry now flourishes after start-up and growth stages. Along with steady improvement in economic environment, rising per-capita disposable income, greater awa...

China Independent Clinical Laboratory Industry Report, 2017-2021

China's independent clinical laboratory industry started late, and is still in its infancy. In 2016, it only saw the penetration rate of about 4%, far below 40% or more in Europe, the United States an...

China Human Vaccine Industry Report, 2017-2021

The human vaccine industry presented the following main characteristics in 2016 in China: 1. Lot release volume of human vaccines declined.Affected by the illegal vaccine case in Mar 2016 in Shandong...

China Independent Clinical Laboratory Industry Report, 2016-2020

Owing to a large population base, uneven distribution of medical resources among regions, aging population, and continuous advance of health care reform, the Chinese independent clinical laboratory ma...

China Human Vaccine Industry Report, 2016-2020

Amid the unsafe domestic vaccine events, China’s human vaccine lot release volume in 2015 fell by 17.9% year on year to only 650 million doses,touching a 5-year low. Moreover, with the improvements in...

China Animal Vaccine Industry Report, 2016-2020

Animal vaccine is a kind of biological agent that enables inoculated animals to produce active immunity for disease prevention. In recent years, European and American animal vaccine markets have seen ...

China Blood Product Industry Report, 2016-2019

Recombinant blood products have developed for many years in foreign countries, but China’s blood products are still proteins extracted from human blood. Thus, reserves and control of plasma resources ...

China Contract Research Organization (CRO) Industry Report, 2015-2018

In recent years, China's contract research organization (CRO) industry has developed rapidly, with the market size rising from RMB8.5 billion in 2007 to RMB42.6 billion in 2014, registering a CAGR of ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号